Učitavanje...
Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial
BACKGROUND: Two large clinical trials have shown a reduced rate of breast cancer development in high-risk women in the initial 5 years of follow-up after use of aromatase inhibitors (MAP.3 and International Breast Cancer Intervention Study II [IBIS-II]). Here, we report blinded long-term follow-up r...
Spremljeno u:
| Izdano u: | Lancet |
|---|---|
| Glavni autori: | , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6961114/ https://ncbi.nlm.nih.gov/pubmed/31839281 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(19)32955-1 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|